CSPC Pharmaceutical (1093 HK) – Innovative Platforms to Drive Future Growth
NBP recorded sales growth of 10.8% YoY in 1Q23, while pressures remain on the future sales of NBP upon the launch of generics and NBP’s inclusion...
China Macro: Sector Positioning Update
Sector positioning among active China Funds. Industrials and Consumer Staples Remain Top Overweights, Energy shows signs of a turnaround, whilst...
China's Weight Loss Drug Market – The Investment Opportunities and the Risks Behind
The GLP-1 target has been recognized as a blockbuster target, which has attracted great enthusiasm from investors.We analyzed related investment...
Smartkarma Originals